SARS-CoV-2 excretion and genetic evolution in nasopharyngeal and stool samples from primary immunodeficiency and immunocompetent pediatric patients
Virol J. 2025 Jan 13;22(1):9. doi: 10.1186/s12985-025-02628-7. ABSTRACT BACKGROUND: Primary Immunodeficiency disorders (PID) can increase the risk of severe COVID-19 and prolonged infection. This study …